Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-12

FDA Approved: ZOMIG — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for ZOMIG (zolmitriptan) submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zomig (Zolmitriptan)

Snippet

SUPPL AP for ZOMIG (ZOLMITRIPTAN)